Given that androgen receptor (AR) signaling is a key driver of the tumor phenotype in both treatment-naïve [36] and castration-resistant prostate cancer [37, 38], we investigated if AR is able to regulate PBK expression. The gene discussed is AR; the disease is prostate carcinoma.